Regeneron, Sanofi Present Positive Results from Pivotal Phase 3 Study of Sarilumab at ACR Annual Meeting
November 08, 2015 at 08:29 AM EST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) today announced results from a pivotal Phase 3 study of sarilumab, ...